Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenner PLC Regulatory News (FENR)

  • There is currently no data for FENR

Acquisition

2 Feb 2015 07:00

RNS Number : 6949D
Fenner PLC
02 February 2015
 

02 February 2015

Fenner PLC ("Fenner")

Acquisition of Charter Medical Limited ("Charter")

Fenner is pleased to announce that its wholly owned subsidiary Fenner Drives, Inc. has acquired 100% of the share capital of Charter from its parent company Lydall, Inc. a publicly traded company (NYSE: LDL) headquartered in Connecticut. Charter will be integrated into Solesis Medical Technologies ("Solesis"), part of Fenner's AEP division.

The consideration of US$29.9m was satisfied in cash at completion and the transaction is expected to be earnings enhancing immediately upon acquisition.

Charter manufactures specialty single-use assemblies and Class I and Class II medical devices for the collection, processing, storage and filtration of biological and bioprocessing fluids. Charter also produces bio-containers and fluid management sets that serve a range of life science applications including biopharmaceutical manufacturing, cell therapy and cryogenic storage. Charter is a single site company based in Winston-Salem, North Carolina.

As at 31 December 2014, unaudited gross assets acquired were US$6.9m with underlying EBITDA (1) of US$3.3m for the 12 months to 31 December 2014 on sales of US$19.6m. 

The entire workforce of Charter have become employees of Fenner upon completion and will continue to be led by General Manager, Mr. Gael Peron.

Nick Hobson, CEO of Fenner PLC, commented:

"In common with all businesses in our AEP division, Charter applies its polymer technology to solving problems in performance-critical applications. Charter has a strong, established business in blood transfusion and filtration markets and has exciting opportunities in the bio-processing and regenerative medicine markets, in which Fenner is already active and which are experiencing rapid growth. 

The acquisition of Charter, which will provide an attractive addition to the capabilities and offerings of Solesis, continues Fenner's strategy to develop our medical business both organically and by acquisition."

For further information please contact:

 

Fenner PLC 01482 626501

Nick Hobson, Chief Executive

John Pratt, Finance Director

 

Weber Shandwick Financial 020 7067 0700

Nick Oborne / Tom Jenkins

 

 

(1) Adjusted for historic non-recurring items

 

Notes to editors:

 

Fenner PLC is a world leader in reinforced polymer technology, providing local engineered solutions for performance-critical applications. The Group operates through two divisions:

Engineered Conveyor Solutions: the ECS division, trading under the Fenner Dunlop, Fenner and Dunlop brand names, is a recognised leader in the global conveying market. The division offers a unique, comprehensive suite of products and services, which serve the conveying needs of mining, power generation and bulk handling markets.

Advanced Engineered Products: the AEP division uses advanced polymeric materials and technical expertise to provide high value-added solutions to customers' most challenging engineering problems. Customers are spread across a variety of end-user segments, including oil & gas and medical which account for some 40 per cent of divisional revenue, together with construction, transportation, automation and general industrial. AEP's trading names are recognised globally and include CDI Energy Products, EGC Critical Components, Hallite, AIP Precision Machining, Fenner Precision, Fenner Drives, James Dawson, Mandals, Secant Medical and Xeridiem.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUARWRVBAURAR
Date   Source Headline
20th Jan 20177:00 amRNSResult of AGM
18th Jan 20179:25 amRNSHolding(s) in Company
17th Jan 201711:41 amRNSDirector/PDMR Shareholding
13th Jan 20173:17 pmRNSHolding(s) in Company
13th Jan 20173:05 pmRNSDirector/PDMR Shareholding
13th Jan 20172:59 pmRNSDirector/PDMR Shareholding
13th Jan 20172:57 pmRNSDirector/PDMR Shareholding
12th Jan 201711:01 amRNSResult of AGM
12th Jan 201710:57 amRNSDirectorate Change
9th Jan 201710:03 amRNSHolding(s) in Company
6th Jan 20177:00 amRNSTrading Update
4th Jan 20174:41 pmRNSShareholder Requisition Updated Statement 2017
28th Dec 20167:00 amRNSProposed Directorate Change
20th Dec 20169:06 amRNSDocuments available for viewing
20th Dec 20167:00 amRNSDirectorate Change
16th Dec 20167:00 amRNSAdditional AGM Resolution
13th Dec 201611:06 amRNSDocuments available for viewing/Notice of AGM
30th Nov 20161:38 pmRNSHolding(s) in Company
25th Nov 201612:06 pmRNSDirector/PDMR Shareholding
21st Nov 20163:03 pmRNSHolding(s) in Company
16th Nov 20167:00 amRNSFinal Results
20th Oct 20163:32 pmRNSHolding(s) in Company
13th Oct 20162:15 pmRNSHolding(s) in Company
29th Sep 20164:14 pmRNSHolding(s) in Company
8th Sep 20167:00 amRNSPre-Close Trading Statement
2nd Sep 20169:01 amRNSDisposal
1st Sep 201610:42 amRNSBlock listing Interim Review
29th Jul 20169:40 amRNSHolding(s) in Company
13th Jul 20167:00 amRNSTrading Update
6th Jul 20164:51 pmRNSCapital Reduction
30th Jun 20162:13 pmRNSHolding(s) in Company
23rd Jun 20169:50 amRNSHolding(s) in Company
8th Jun 20167:00 amRNSBoard Changes
29th Apr 201610:11 amRNSHolding(s) in Company
27th Apr 20167:00 amRNSHalf-year Report
4th Apr 201610:41 amRNSDirectorate Change
22nd Mar 20162:22 pmRNSHolding(s) in Company
10th Mar 20167:00 amRNSPre-Close Trading Statement
8th Mar 201610:31 amRNSHolding(s) in Company
1st Mar 20163:22 pmRNSBlocklisting Interim Review
15th Jan 201610:12 amRNSResult of AGM
13th Jan 20167:00 amRNSRestructuring of ECS Americas and AGM Update
5th Jan 20167:00 amRNSInterim Board Change
21st Dec 20151:50 pmRNSHolding(s) in Company
10th Dec 201512:24 pmRNSDocuments available for viewing/Notice of AGM
20th Nov 201512:53 pmRNSHolding(s) in Company
20th Nov 20159:03 amRNSDirector/PDMR Shareholding
13th Nov 201511:04 amRNSHolding(s) in Company
11th Nov 20157:15 amRNSDirectorate Change
11th Nov 20157:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.